Chorea-acanthocytosis: Clinical and genetic findings in three families from the Arabian peninsula

Movement Disorders

Volumn 18, Issue 4, 2003, Pages 403-407

  Bohlega, Saeed ^a   Al Jishi, Adel ^b   Dobson Stone, Carol ^c   Rampoldi, Luca ^c,d   Saha, Parthasarathi ^e   Murad, Hatem ^a   Kareem, Abid ^a   Roberts, George ^a   Monaco, Anthony P ^c  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b Suleimania Medical Centre   (Bahrain)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e Assir General Hospital   (Saudi Arabia)

Author keywords

Acanthocytosis; Autosomal recessive; Chorea acanthocytosis; Gene mutations; Prebetalipoprotein

Indexed keywords

CLONAZEPAM; FLUORODEOXYGLUCOSE F 18; GABAPENTIN; LIPID; RISPERIDONE; VERY LOW DENSITY LIPOPROTEIN;

ACANTHOCYTOSIS; ADULT; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; BEHAVIOR DISORDER; BLOOD ANALYSIS; BRAIN ATROPHY; BRAIN METABOLISM; CAUDATE NUCLEUS; CHOREA; CHROMOSOME 9Q; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORPUS STRIATUM; DNA FLANKING REGION; ELECTRON MICROSCOPY; ELECTROPHORESIS; FEMALE; GAIT DISORDER; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; GENETIC MARKER; HOMOZYGOSITY; HUMAN; LIPID ANALYSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PHASE CONTRAST MICROSCOPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; SAUDI ARABIA; SCHIZOPHRENIA; SEIZURE; TIC;

ACANTHOCYTES; ADULT; ARABS; ATROPHY; CAUDATE NUCLEUS; CHOREATIC DISORDERS; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 9; CODON, NONSENSE; CORPUS STRIATUM; DNA MUTATIONAL ANALYSIS; FEMALE; FRAMESHIFT MUTATION; GENES, RECESSIVE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PEDIGREE; PROTEINS; PUTAMEN; SAUDI ARABIA; TOMOGRAPHY, EMISSION-COMPUTED; VESICULAR TRANSPORT PROTEINS;

EID: 0037732993     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10361     Document Type: Article

References (24)

1. Critchley EMR, Clark DB, Wiklen A. Acanthocytosis and neurological disorder without abetalipoproteinemia. Arch Neurol 1968; 18:134-140.
2. Levine IM, Estes JW, Ioonez JM. Hereditary neurological disease with acanthocytosis: a new syndrome. Arch Neurol 1968;19:403-409.
3. Hardie RJ, Pullon HW, Harding AE, et al. Neuroacanthocytosis: a clinical, hematological and pathological study of 19 cases. Brain 1991;114:13-49.
4. Hardie RJ. Acanthocytosis and neurological impairments [review]. QJM 1989;264:291-306.
5. Stevenson U, Hardie RJ. Acanthocytosis and neurological disorder. J Neurol 2001;248:87-94.
6. Rinne JO, Daniel SE, Scaravilli F, Pines M, Harding AE, Marsden CD. The neuropathological features of neuroacanthocytosis. Mov Disord 1994;9:297-304.
7. Rubio JP, Danek A, Stone C, et al. Chorea-acanthocytosis: genetic linkage to chromosome 9q21. Am J Hum Genet 1997;61:899-908.
8. Rampoldi L, Dobson-Stone C, Rubio JP, et al. A conserved sorting-associated protein is mutant in chorea-acanthocytosis. Nat Genet 2001;28:119-120.
9. Ueno S, Maruki Y, Nakamura M, et al. The gene encoding a newly discovered protein chorein is mutated in chorea-acanthocytosis. Nat Genet 2001;28:121-122.
10. Drurez G. Un nouveau cas d'acanthocytosis. Rev Hemat 1959;14: 3-11.
11. Bohlega S, Riley W, Powe J, Baynton R, Roberts G. Neuroacanthocytosis and a prebetalipoproteinemia. Neurology 1998;50:1912-1914.
12. Dobson-Stone C, Danek A, Rampoldi L, et al. Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis. Eur J Hum Genet 2002;10:773-781.
13. Orfner PJ, Underhill PA. Comparative DNA sequencing by denaturing high-performance liquid chromatography (DHPLC). Am J Hum Genet 1995;57(Suppl):A266.
14. Aminoff MJ. Acanthocytosis and neurological disease. Brain 1972;95:749-760.
15. Vance JM, Pericak-Vance MA, Bowman M, et al. Chorea-acanthocytosis: a report of three new families and implications for genetic counseling. Am J Med Genet 1987;28:403-410.
16. Oshimu M, Osawa Y, Asahu K, Saito T. Erythrocyte membrane abnormalities in patients with amyotrophic chorea and acanthocytosis. J Neurol Sci 1985;68:147-160.
17. Dubinsky R, Hallet M, Casey R, Chiro G. Regional brain glucose metabolism in neuroacanthocytosis. Neurology 1989;39:1253-1255.
18. Brook DJ, Ibanez V, Playfford ED, et al. Presynaptic and post synaptic striatal dopaminergic function in neuroacanthocytosis; a positron tomographic study. Ann Neurol 1991;30:166-171.
19. Spitz MC, Jankovic J, Killian TM. Familial tic disorder, parkinsonism, motor neuron disease and acanthocytosis: a new syndrome. Neurology 1985;33:366-370.
20. Rinne JO, Daniel SE, Scaravilli F, Harding AE, Marsden CD. Nigral degeneration in neuroacanthocytosis. Neurology 1994;44: 1629-1632.
21. De Yebenes JG, Brin MF, Mena MA, et al. Neuro-chemical findings in acanthocytosis. Mov Disord 1988;3:300-312.
22. Bird TD, Cederbann S, Valping W, Stahl WR. Familial regeneration of the basal ganglia with acanthocytosis: a clinical, pathological and neurochemical study. Ann Neurol 1978;3:253-258.
23. Higgins JY, Patterson ME, Papadopoulous NM, et al. Hypoprebetalipo-proteinemia acanthocytosis retinitis pigmentosa and pallidal degeneration (HARP syndrome). Neurology 1992;42:194-198.
24. Ornel RW, Ammarlia PJ, Heald A, et al. Acanthocytosis, retinitis pigmentosa and pallidal degeneration. A report of three patients, including the second reported case with hypoprebetalipoproteinemia (HARP syndrome). Neurology 1995;45:487-492.